Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Sulaiman Al Habib Medical Services GroupSAU:4013 -1.64%91 5-Year Yield-on-Cost % is 6.35 as of Aug. 16, 2026, which is 44% above its 10-year median of 4.41. GuruFocus rates SAU:4013 with a GF Score™ of 91/100 and a GF Value™ of ﷼376.35 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Dr Sulaiman Al Habib Medical Services Group ranks better than 80.87% on this metric.
SAU:4013's 5-Year Yield-on-Cost % is ranked better than 80.87% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.87
vs SAU:4013: 6.35
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Dr Sulaiman Al Habib Medical Services Group 5-Year Yield-on-Cost % Related Terms
SAU:4013 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost % falls into.
Dr Sulaiman Al Habib Medical Services Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a 5-Year Yield-on-Cost % of 6.35 as of Aug. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. This is 44% above median its historical median of 4.41. Over the past decade, Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost % has ranged from 1.52 to 6.76. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #53 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 19.1%.
Is Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost % too high?
Dr Sulaiman Al Habib Medical Services Group's current 5-Year Yield-on-Cost % of 6.35 is 44% above median its 10-year median of 4.41. Over the past 10 years, this metric has ranged from a low of 1.52 to a high of 6.76. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.87. Dr Sulaiman Al Habib Medical Services Group's value of 6.35 is 121.3% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #53 out of 277 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #53 out of 277 companies for 5-Year Yield-on-Cost %. This places Dr Sulaiman Al Habib Medical Services Group in the top 19% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.87. Dr Sulaiman Al Habib Medical Services Group's value of 6.35 is 121.3% above this benchmark. Historically, Dr Sulaiman Al Habib Medical Services Group's own 5-Year Yield-on-Cost % has ranged from 1.52 to 6.76 over the past decade. While the company's 10-year median is 4.41 vs. the industry median of 2.87, Dr Sulaiman Al Habib Medical Services Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.87, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current 5-Year Yield-on-Cost % of 6.35 is 121.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current 5-Year Yield-on-Cost % is 6.35, which is 44% above median its own 10-year median of 4.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼376.35, compared to a current price of ﷼228.40 — trading 39.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.35, which is 44% above median its 10-year median of 4.41 and 121.3% above the Healthcare Providers & Services industry median of 2.87. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current 5-Year Yield-on-Cost % is 6.35 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼228.40 is trading 39.3% below its estimated GF Value™ of ﷼376.35.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
5-Year Yield-on-Cost %: 6.35 (44% above median its 10-year median of 4.41)
GF Value™: ﷼376.35 vs. price of ﷼228.40 (39.3% below fair value)
Industry Position: 121.3% above the Healthcare Providers & Services median (#53 of 277)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
91GF Score
Get the complete analysis for SAU:4013
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
